ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,799, issued on July 15, was assigned to Tufts Medical Center Inc. (Boston).
"Systems and methods for selectively occluding the superior vena cava for treating heart conditions" was invented by Navin K. Kapur (Hanover, Mass.) and Richard Karas (Franklin, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods and devices are provided for treating conditions such as heart failure and/or pulmonary hypertension by at least partially occluding flow through the superior vena cava for an interval spanning multiple cardiac cycles. A catheter with an occlusion device is provided along with a controller that actuates a drive mechanism to prov...